Covid-19 vaccine

COVID-19 : Pfizer/BioNTech vaccine Approved for use Nextweek

- ADVERTISEMENT -

COVID-19 vaccine , Pfizer/BioNTech vaccine  will be approved for use next week in the UK, as the UK becomes the first country in the world to approve the Pfizer/BioNTech COVID-19 vaccine. As of next week, the first 800,00 doses will be available in the UK.

covid-19

The Elderly people in care homes and care home staff are top of the important list.

- ADVERTISEMENT -

However, the first vaccinations are most likely to take place at hospitals because of the limited stocks and need to store at 70C.

The Pfizer/ BioNTech jab is the quickest vaccine to go from concept to fact, taking only 10 months to follow the same steps that normally span 10 years.

Already, The UK has already ordered 40 million doses of the free jab, enough to vaccinate 20 million people.

The world’s big powers have been competing for months in an attempt to be the first to begin the long road to recovery.

The United States drugmaker said Britain’s emergency use authorization marks a historic moment in the fight against COVID-19.

Every day, about 450 people dyes of COVID-19 infection in the UK, and the interest of quick approval outweigh the potential risks.

So far, The government has ordered 40 million doses of the COVID-19 vaccine with 10 million due in the UK by of 2020.

The order in which people will get the jab is decided by the Joint Committee on Vaccinations and Immunisations.

The  COVID-19 vaccines must be stored, kept, and shipped at ultra-cold temperatures of around minus 70 degrees Celsius.

COVID-19 vaccine: Tested in Tens of Thousands

The early result indicates the COVID-19 vaccine is 95% effective at preventing mild to serious COVID-19 disease

Also, the vaccine has been tested in only a small number of children, non younger than 12. There is also no updates on its effects on women who are pregnant.

They are no serious side effects of COVID-19 vaccines. The vaccine recipients may experience some pain and flu-like reactions quickly after injections.

The United States Food and Drug Administration is planning to meet on December 10 to analyze the COVID-19 vaccine. And could permit the use of the shot soon after.

This is the news everybody has all been expecting. The vaccine was 95% effective for all groups in the trials, even the elderly people.

It will have to be tested again each time a new batch is sent over. It is advisable, that everyone continues to play their part and abide by the compulsory restrictions.

A Historic Moment

This shows the first time that citizens outside of the worldwide clinical trials will have the chance to be immunized against viruses.

Before the end of the year, Other countries, including the United States, are thinking to accept various coronavirus vaccines.

- ADVERTISEMENT -

The supply of the vaccines will most likely slope up into the millions. Itwill show how quickly Pfizer can manufacture in Belgium. It is the protectio of vaccines that will allow lives toget back in shaoe and economy to move again

Facebook Comments
If you have a story you want to tell, send it to Cinema9ja Ent. via [email protected]